ONVO has not been a TRADERS' DREAM on the long side unless nimbly playing FLIPS in the shadow of shorting activity...
but for those investing in ONVO for its R&D pipeline that is going to offer skin assays for testing (DONE), liver assays for testing(DONE), kidney assays for testing, and perhaps one day be involved with therapeutic tissues for medical implant...
then ONVO is moving right along with positive achievements on technical R&D milestones...
and has moved from a $2 OTC stock to a $7 uplisted stock!